Can a new governor, an oligarch from the region, restore calm in the face of a depressed economy, corruption, and a pro-Russian political establishment?
Lamborghini, Ferrari, Maserati, McLaren, and Porsche are all popular among the filthy rich
The U.S. provides hope that much of the world could eventually avoid both malnutrition and excess nutrition
Microsoft's Xbox One sales need a big boost from exclusive game Titanfall
Comcast might please shareholders by spinning off some 3 million subscribers. How long could the new cable company survive independently?
Groups representing professional photographers prefer to develop ways to pay image creators in place of Getty's tolerance for Web embedding
DIsney's MyMagic+ technology may make a trip to Disney World more magical—or creep customers out
European MBA programs compete with top-tier U.S. schools for the best students at home and abroad
Research suggests that women may turn to entrepreneurship after 50 to support themselves in retirement
Founders: Dr. Mark Chandler and Craig Benson (The company was formed in 1998 as a wholly owned subsidiary of Luminex Corp. (LMNX) and subsequently spun off in 2002 as a private management-owned entity.)
VC Investment over the last four quarters: $25 million
With 95 employees worldwide, Rules-Based Medicine, a biomarker testing company, is actively developing diagnostic tests to detect the presence of complex diseases and conditions in the areas of neuropsychiatry, nephrology, immunology, and cardiology. The company is also developing what it calls the first fully closed reproducible whole-blood culture system. Despite the recession, Rules-Based Medicine's founders remain optimistic about its prospects and those of its peers that promote efficiency and cost savings for drug development and diagnostics customers.
Key to startup success: "We took a customer-focused approach to biotechnology, which drove our decision to commit resources to developing much needed comprehensive biomarker content. ... Our customers have essentially directed and funded our R&D since inception."